No Result

View All Result

No products in the cart.

Home All Specialties Chronic Disease

#VisualAbstract Fondazione Italiana Linfomi (FIL) Phase 3 trial: Lenalidomide maintenance after autologous haematopoietic stem-cell transplantation (HSCT) in mantle cell lymphoma improves progression-free survival (PFS)

byKathleen Lau

January 8, 2021

in Chronic Disease

RELATED REPORTS

Chimeric antigen receptor T-cell therapy may induce sustained remission in multirefractory autoimmune hemolytic anemia

Isotonic Fluids Reduce Hyponatremia in Hospitalized Children

Palbociclib as adjunct maintenance therapy prolongs progression-free survival in some types of metastatic breast cancer

Carboplatin as a potential adjunct therapy for recurrent high-grade glioma treatment

RelatedReports

HPV-targeted T-cell therapy may induce cervical cancer regression

Hematology

Chimeric antigen receptor T-cell therapy may induce sustained remission in multirefractory autoimmune hemolytic anemia

February 6, 2026

Pediatric palliative care outcome measures often miss quality of life

Pediatrics

Isotonic Fluids Reduce Hyponatremia in Hospitalized Children

February 4, 2026

Majority of pediatric medication-related visits to emergency department are preventable

Oncology

Palbociclib as adjunct maintenance therapy prolongs progression-free survival in some types of metastatic breast cancer

January 28, 2026

Reduced venous recanalization after acute deep vein thrombosis associated with post-thrombotic syndrome

Chronic Disease

Effect of high elevation on deep vein thrombosis: a multicenter cohort study

January 22, 2026

Decreased expression of nasal ACE2 may be correlated with lower prevalence of COVID-19 in children

2 Minute Medicine Rewind January 11, 2021

Lansoprazole not effective for the treatment of persistent throat symptoms

#VisualAbstract: Occult Blood in Feces Is Associated With an Increased Risk of Ischemic Stroke and Myocardial Infarction

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

No Result

View All Result